These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8563100)

  • 21. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L; Y T; X P; L W; H W; Z S; H Z; Z H;
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients.
    Alvarado AS; Malvar A; Lococo B; Alberton V; Toniolo F; Nagaraja HN; Rovin BH
    Lupus; 2014 Jul; 23(8):840-7. PubMed ID: 24401872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
    Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.
    Yokoyama H; Wada T; Hara A; Yamahana J; Nakaya I; Kobayashi M; Kitagawa K; Kokubo S; Iwata Y; Yoshimoto K; Shimizu K; Sakai N; Furuichi K;
    Kidney Int; 2004 Dec; 66(6):2382-8. PubMed ID: 15569330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The course and treatment of lupus nephritis.
    Appel GB; Valeri A
    Annu Rev Med; 1994; 45():525-37. PubMed ID: 8198400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of gallium-67 scintigraphy in monitoring the renal activity in lupus nephritis.
    Lin WY; Lan JL; Cheng KY; Wang SJ
    Scand J Rheumatol; 1998; 27(1):42-5. PubMed ID: 9506877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal pathology and long-term outcome in childhood SLE.
    Sumboonnanonda A; Vongjirad A; Suntornpoch V; Laohapand T; Parichatikanond P
    J Med Assoc Thai; 1998 Nov; 81(11):830-4. PubMed ID: 9803081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of serial kidney biopsies in lupus nephritis.
    Alsuwaida AO
    Mod Rheumatol; 2014 May; 24(3):453-6. PubMed ID: 24251991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
    Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J
    Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-quantitative evaluation of gallium-67 scintigraphy in lupus nephritis.
    Lin WY; Hsieh JF; Tsai SC; Lan JL; Cheng KY; Wang SJ
    Eur J Nucl Med; 2000 Nov; 27(11):1626-31. PubMed ID: 11105818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus nephritis. Clinicopathological correlation.
    Al-Zahrani IH; Qayyum A
    Saudi Med J; 2007 Oct; 28(10):1503-5. PubMed ID: 17914508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological study of the WHO classification in childhood lupus nephritis.
    Zappitelli M; Duffy C; Bernard C; Scuccimarri R; Watanabe Duffy K; Kagan R; Gupta IR
    Pediatr Nephrol; 2004 May; 19(5):503-10. PubMed ID: 15022106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal biopsy in lupus nephritis.
    Grande JP; Balow JE
    Lupus; 1998; 7(9):611-7. PubMed ID: 9884098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus nephritis in children--a review of 167 patients.
    Yang LY; Chen WP; Lin CY
    Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
    Hill GS; Delahousse M; Nochy D; Bariéty J
    Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
    Mok CC; Ho CT; Siu YP; Chan KW; Kwan TH; Lau CS; Wong RW; Au TC
    Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.